A Historic Shift in Federal Drug Policy

For the first time in decades, the federal government is moving toward reclassifying marijuana at the federal level — a shift with profound implications for communities that have been disproportionately targeted by the war on drugs. While this development opens the door for vital medical research and more inclusive industry growth, it does not legalize marijuana for recreational use at the federal level.

What the Reclassification Means

The reclassification moves marijuana to a lower drug schedule, acknowledging its medical value and reducing the severity of its classification under federal law. This is a significant policy milestone. However, those celebrating should remain clear-eyed: the fight is far from over.

The Department of Justice has announced it will hold a public hearing on June 29 to consider a broader general reclassification — a move that could completely reshape national drug policy. This hearing represents a critical opportunity for advocates, community members, and impacted individuals to make their voices heard.

Why This Matters for Black Communities

For generations, Black Americans have been disproportionately arrested, prosecuted, and incarcerated for marijuana-related offenses — even in states where marijuana use is now legal. The racial disparities in drug enforcement have torn apart families, disrupted communities, and created barriers to employment, housing, and education that persist to this day.

Any reclassification policy must include robust provisions for expungement of prior convictions, reinvestment in communities most harmed by the war on drugs, and equitable access to the legal cannabis industry for Black entrepreneurs.

What to Watch For

• June 29 DOJ Hearing: Advocate for full descheduling and community reinvestment
• Expungement legislation: Push for automatic expungement of marijuana-related convictions
• Cannabis industry equity: Ensure Black entrepreneurs have meaningful access to licensing and capital in the growing cannabis market

Progress is being made — but the measure of true justice will be whether these changes actually reach the people who have paid the highest price for failed drug policies.